Experts demand compulsory licensing for generic production of a drug against COVID-19

Should not a medicine (Remdesivir) that has shown lifesaving effect in certain cases of Covid-19 be made available to all those who need it without delay? Even if Big Pharma has a patent, there are provisions in the global trade treaties that allow governments to issue compulsory licenses to such a lifesaving drug, and keep people over profit.

Click Here To View Original Article